Active	Status	Sponsor type	Region	Phase	Filter
9 Active 0 Inactive 9 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

9 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
McKenzie, Mark
QWINT-1, NCT05662332: A Study of Insulin Efsitora Alfa (LY3209590) Compared to Glargine in Adult Participants With Type 2 Diabetes Who Are Starting Basal Insulin for the First Time	Completed	3	795	US, RoW	Insulin Efsitora Alfa, LY3209590 and Basal Insulin-FC, Insulin Glargine	Eli Lilly and Company	Type 2 Diabetes, T2D	07/24	07/24
SURMOUNT-5, NCT05822830: A Study of Tirzepatide (LY3298176) in Participants With Obesity or Overweight With Weight Related Comorbidities	Completed	3	751	US	Tirzepatide, LY3298176, Semaglutide	Eli Lilly and Company	Obesity, Overweight	11/24	11/24
SURMOUNT-MMO, NCT05556512: A Study of Tirzepatide (LY3298176) on the Reduction on Morbidity and Mortality in Adults With Obesity	Active, not recruiting	3	15374	Europe, Canada, Japan, US, RoW	Tirzepatide, LY3298176, Placebo	Eli Lilly and Company	Obesity, Overweight	10/27	10/27
NCT05468736: Study to Evaluate Safety and Immunogenicity of COVID-19 Vaccine in Children 6 Months to < 12 Years	Active, not recruiting	2/3	3600	Europe, US, RoW	SARS-CoV-2 rS/Matrix-M1 Adjuvant (Initial Vaccination Period), NVX-CoV2373, Placebo, Sodium chloride 0.9% (BP, sterile)	Novavax	COVID-19	01/24	10/25
NCT04845178: Investigation of Safety and Efficacy of ABP-450 for Migraine Prevention in Adults	Completed	2	797	NA	ABP-450, prabotulinumtoxinA, Placebo, 0.9% sodium chloride, saline	AEON Biopharma, Inc., PPD	Migraine	06/24	08/24
NCT04505436: Study to Evaluate Efficacy, Safety and Tolerability of HM15211 in Subjects	Recruiting	2	240	US, RoW	HM15211, Placebo of HM15211	Hanmi Pharmaceutical Company Limited	NASH - Nonalcoholic Steatohepatitis	05/26	11/26
NCT03952364: The PRECIOUS Study: Predicting Crohn's & ColitIs Outcomes in the United States	Recruiting	N/A	200	US	PredictSURE IBD™	PredictImmune Ltd, The Crohn's and Colitis Foundation	Crohn Disease, Ulcerative Colitis, IBD, Inflammatory Bowel Diseases	06/22	06/22
ECLIPSE, NCT04136002: Evaluation of the ctDNA LUNAR Test in an Average Patient Screening Episode	Active, not recruiting	N/A	44467	US		Guardant Health, Inc., Premier Research Group plc	Colorectal Cancer	03/24	12/25
Osmundsen, Erica
STARFISH, NCT05727202: Project - PRJ0002679	Completed	N/A	1909	US	The Applied Biosystems™ TaqPath™ COVID-19, Flu A, Flu B, RSV Select Panel	Thermo Fisher Scientific, Inc, NAMSA	SARS-CoV-2 Infection, Influenza A, Influenza Type B, RSV Infection	04/24	04/24